D

Duke University Health System | Duke Gastroenterology Clinic - Clinic 2

Research site
(Unclaimed)
Location
40 Medicine Circle, orange zone basement Rm 0341, Durham, North Carolina, United States of America
Site insights

Top conditions

Plasma Cell Cancer (1 trial)

Small Cell Lung Carcinoma (1 trial)

Multiple Myeloma (1 trial)

Lung Cancer (1 trial)

Top treatments

Ifinatamab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 2
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (CaMMouflage)

This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that tar...

Enrolling
Relapsed/Refractory Multiple Myeloma
Biological: CB-011

This 2-part study intends to define the recommended Phase 2 dose of ifinatamab deruxtecan (I-DXd) based on the efficacy, safety, and pharmacokinetics...

Enrolling
Extensive-stage Small-cell Lung Cancer
Drug: Ifinatamab Deruxtecan (I-DXd)

Trial sponsors

C

Caribou Biosciences (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems